CANADA change location▼
Collaborating in more than 150 countries.By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com.These sections or websites are governed by their own Legal and Privacy Policies.
Janssen Global
English | Español Français | Português (BR) Italiano | 한국어 РУССКИЙ
Asia Pacific (Regional)
English
Australia
China
中文
India
Japan
日本
Korea
한국어
New Zealand
EMEA (Regional)
Austria
Deutsch
Belgium
English | Français | Nederlands
Bulgaria
Български
Croatia
HRVATSKI
Czech Republic
Čeština
Denmark
Dansk
Estonia
Finland
Suomi
France
Français
Germany
Greece
ΕΛΛΗΝΙΚΑ
Hungary
Magyar
Ireland
Israel
עברית
Italy
Italiano
Kazakhstan
Русский
Latvia
Lithuania
Netherlands
Nederlands
Norway
Norsk
Poland
Polski
Portugal
Português
Romania
Română
Russia
Serbia
SRPSKI
Slovakia
SLOVENČINA
Slovenia
Slovenščina
South Africa
Spain
Español
Sweden
Svensk
Switzerland
Deutsch | Français
Turkey
Türkçe
United Kingdom
Argentina
Bolivia
Brazil
Central America and the Caribbean
Spanish | English
Chile
Colombia
Ecuador
Mexico
Paraguay
Peru
Uruguay
Canada
English | Français
United States
Welcome to Janssen Canada
VISIT JANSSEN GLOBAL
Coronavirus Disease (COVID-19) Update
Addressing the COVID-19 Crisis in Canada
Access and Affordability Support for Patients
5 Ways Janssen Canada is Helping in the Fight Against COVID-19
Treatments that give hope and health to patients and their loved ones
Access to medical information about products supported by Janssen
Free assistive technology software for people with disabilities.
Important Safety Information on DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
Please visit Our Products to review previous safety communications by product.
